About 2 years ago a milestone was set in the Belgian Advanced Therapy Medicinal Products (“ATMP”) legislation. The publication took place on October 30th 2018, modifying the law of December 19th 2008 regarding the collection and use of human body material for the purpose of human therapeutic applications or scientific research. This law enables progress in the development of new, innovative therapies based upon handling of human cells and tissues for the production of medicines. Discover the most important elements of this law during the bio.be WEBINAR on February 9th from 13h30 till 14h30.
Who is bio.be?
bio.be is the Belgian federation representing the biotech and the life sciences industry. It operates under the aegis of umbrella organisation essenscia. Bio.be’s members are part of an effective advocacy and regulatory voice representing the collective interests of the Belgian life sciences and biotechnology community. Bio.be has the tools to help its members’ business reach its full potential – from R&D to growth and excellence in biomanufacturing – through advocacy, communications and membership services.
Who is the speaker?
Marc Martens is board member of bio.be and partner of Bird & Bird. He is co-head of Bird & Bird’s International Life Sciences & Healthcare group and head of Bird & Bird’s Regulatory, Public & Administrative Law group in Brussels. He offers both contentious and non-contentious strategic advice to Belgian and international pharma, biotech and medical devices companies, public bodies and national and European industry associations facing complex regulatory frameworks. His areas of expertise cover issues relating to life-cycle management, clinical trials and data, data exclusivity, marketing, price and reimbursement authorizations, and e-health together with data protection, distribution and advertising issues. He provides advice to biotech companies on issues regarding Advanced Therapy Medicinal Products as well as the legal and bioethical issues relating to research and use of human cells and tissues. He regularly represents his clients before the national jurisdictions as well as before the European Court.
Marc Martens holds a law degree from the Vrije Universiteit Brussel (VUB), where he worked for four years as a research assistant, and a degree in public and administrative law from the University of Brussels. Before joining Bird & Bird, he was an expert adviser to the Vice-Prime Minister of Belgium for 3 years.
How to register?
Send an e-mail to info@advancedtherapies.world and you will receive a mail with all the guidance on how to follow this training.”
